What is Infervision?
Infervision specializes in the development of advanced AI-driven imaging solutions designed to augment the capabilities of radiologists and surgical teams. The company's core product suite, including the InferRead and InferOperate platforms, integrates seamlessly into existing hospital infrastructures to enhance diagnostic accuracy and streamline surgical planning. With a global footprint spanning over 25 countries, Infervision leverages a deep portfolio of patents and clinical research to address critical inefficiencies in healthcare delivery, ultimately aiming to improve patient outcomes through precision medicine and automated data analysis.
How much funding has Infervision raised?
Infervision has raised a total of $165M across 3 funding rounds:
Series A
$8M
Series B
$18M
Series D
$139M
Series A (2017): $8M, investors not publicly disclosed
Series B (2017): $18M led by Qiming Venture Partners, Sequoia Capital China, and Genesis Capital
Series D (2021): $139M supported by Goldman Sachs, Z-Park Fund, and CCB Trust
Key Investors in Infervision
Sequoia Capital China
A premier global venture capital firm with an unparalleled track record of partnering with entrepreneurs to build market-leading companies across the technology and healthcare sectors.
Goldman Sachs
A leading global investment banking and management firm that provides strategic advisory and capital to high-growth enterprises, leveraging deep expertise in global financial markets.
Qiming Venture Partners
A prominent venture capital firm specializing in early-stage and growth-stage investments, with a strong focus on the healthcare and technology industries.
What's next for Infervision?
With the recent influx of capital, Infervision is well-positioned to accelerate its international expansion and deepen its R&D efforts in predictive diagnostics. The company is expected to focus on scaling its enterprise-grade solutions, further integrating its AI models into complex clinical environments, and expanding its patent portfolio. As the healthcare industry continues to prioritize digital transformation, Infervision's strategic roadmap likely involves strengthening its market penetration in key regions and fostering deeper partnerships with global medical institutions to solidify its competitive advantage in the rapidly evolving AI-healthcare ecosystem.
See full Infervision company page
